Healthgenic International Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -181.59%
- Ebitda -554.62%
- Net Worth -42.74%
- Total Assets -43.97%
About Healthgenic International
Healthgenic International Private Limited (HIPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 June 2019 (Five years and seven months 29 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Jain and Komal Rastogi serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2019PTC108517
-
Company No.
108517
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Jun 2019
-
Date of AGM
30 Jul 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Healthgenic International?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Jain
|
Director | 06-Jun-2019 | Current |
|
Komal Rastogi
|
Director | 20-Nov-2019 | Current |
Financial Performance of Healthgenic International.
Healthgenic International Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 181.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healthgenic International?
Unlock access to Healthgenic International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Redwing Pharma Private LimitedGaurav Jain is a mutual person
-
Kobun Techno Pharma (Opc) Private LimitedKomal Rastogi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Healthgenic International?
Unlock and access historical data on people associated with Healthgenic International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healthgenic International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healthgenic International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
